Thursday, September 21, 2006
Article in today's New York Times -- F.D.A. Nominee Advances; Hurdles Linger, by Gardiner Harris:
A Senate committee voted on Wednesday to approve Andrew von Eschenbach to
head the Food and Drug Administration, but hurdles to his confirmation remain.
Dr. von Eschenbach has been acting commissioner for a year. Action on his nomination
was held up for six months because of objections from two Democratic senators, and
now two Republicans have promised to delay a confirmation vote for entirely different reasons.